OVARIAN CLEAR CELL CARCINOMA
Clinical trials for OVARIAN CLEAR CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new OVARIAN CLEAR CELL CARCINOMA trials appear
Sign up with your email to follow new studies for OVARIAN CLEAR CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy combo shows promise against rare, tough ovarian cancer
Disease control OngoingThis study tests whether a combination of two immune-boosting drugs (nivolumab and ipilimumab) works better than nivolumab alone for people with advanced clear cell cancers of the ovary, fallopian tube, peritoneum, or other areas. About 46 participants will receive one of the two…
Matched conditions: OVARIAN CLEAR CELL CARCINOMA
Phase: PHASE2 • Sponsor: Brown University • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New drug combo shows promise for tough ovarian cancer
Disease control OngoingThis study tests two drugs, pembrolizumab and lenvatinib, in 30 people with recurrent clear cell ovarian cancer. The goal is to see if the combination can shrink tumors or slow cancer growth. Participants must have had at least one prior treatment and have measurable disease.
Matched conditions: OVARIAN CLEAR CELL CARCINOMA
Phase: PHASE2 • Sponsor: Elizabeth K. Lee MD • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC